Balance Sheet Data
AcelRx Pharmaceuticals, Inc. (ACRX)
$0.2096
-0.00 (-0.14%)
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Total Cash | 60.47 | 105.71 | 66.14 | 42.89 | 12.66 | 58.27 | 61.47 | 64.85 | 68.41 | 72.17 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 1.53 | 0.40 | 0.52 | 0.63 | 0.16 | 0.46 | 0.49 | 0.52 | 0.54 | 0.57 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.96 | 0.85 | 3.29 | 1.63 | 1.11 | 1.58 | 1.66 | 1.75 | 1.85 | 1.95 |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.42 | 2.07 | 1.72 | 2.74 | 2.12 | 1.87 | 1.98 | 2.08 | 2.20 | 2.32 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.41 | -0.82 | -3.47 | -1.85 | -1.79 | -1.89 | -1.99 | -2.10 | -2.22 | -2.34 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.